Dr. Susan Kit-Sum Chu, MD

Dr. Chu practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Chu's NPI, 1033127162, was assigned on August 4, 2006. Dr. Chu graduated from Medical College Of Wisconsin in 1998. Dr. Chu holds California license A71982.

Dr. Chu's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Chu's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Chu is also affiliated with Sharp Memorial Hospital. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Chu to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chu practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Chu's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Chu is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Chu is licensed in California.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, fatty liver, gastroduodenitis and intestinal diverticulosis among the conditions Dr. Chu treats.

CMS data shows 653 Medicare services from Dr. Chu across 7 procedure codes in 2024, for 101 Medicare patients. Medicare paid $28,249 for them. Every service was in an office.

CMS counts 101 Medicare patients who saw Dr. Chu in 2024. The largest group is 65 to 74, with 56 patients. 64% of them have high cholesterol, and 59% have high blood pressure. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chu's median patient age at 63, with 60% women.

In 2024, Dr. Chu wrote 398 Medicare Part D claims for 111 patients. 80% of them were for generic drugs. CMS names the drug for 287 of them, across 13 drugs with 11 or more claims each, at $74,177 in total drug cost. In 2023, CMS named 344 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Chu for performance year 2024, reported as part of a group. Dr. Chu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chu as offering telehealth. CMS counts 64 procedures of colonoscopy by Dr. Chu, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Chu. Dr. Chu's most frequent co-author is Felix W. Leung, MD.

CMS Open Payments shows 18 general payments to Dr. Chu from 8 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $453.

Dr. Chu graduated from Medical College Of Wisconsin in 1998.

Dr. Chu is in network with 6 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.